Keyphrases
Phase I Clinical Trial
100%
Acute Leukemia
100%
Lymphoma
100%
Bone Marrow
100%
Lymphocytes
100%
Chronic Myeloid Leukemia
100%
Counterflow
100%
Lymphocyte Depletion
100%
Centrifugal Elutriation
100%
Bone Marrow Transplantation
66%
Chronic Phase
66%
Disease Status
66%
Early Relapse
66%
Accelerated Phase
66%
T Cells
33%
Efficacy Trial
33%
Cyclosporine
33%
High Risk
33%
Host Disease
33%
Allograft
33%
Engraftment
33%
Remission
33%
Therapy-resistant
33%
Partial Remission
33%
HLA-identical
33%
Median Time
33%
Allogeneic Bone Marrow Transplantation
33%
Sibling Donor
33%
First Remission
33%
Non-reactivity
33%
Absolute Neutrophil Count
33%
Clinical Stage I
33%
Ideal Body Weight
33%
Second Remission
33%
Day Range
33%
Medicine and Dentistry
Clinical Trial
100%
Acute Leukemia
100%
Chronic Myelogenous Leukemia
100%
Lymphocyte Depletion
100%
Lymphocyte
100%
Disease
66%
Bone Marrow Transplantation
66%
Morphology
33%
Host
33%
Engraftment
33%
Allograft
33%
Cyclosporine
33%
T Lymphocyte
33%
Clinical Stage
33%
Allogenic Bone Marrow Transplantation
33%
Absolute Neutrophil Count
33%
Ideal Body Weight
33%
Graft Versus Host Reaction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Acute Leukemia
100%
Remission
100%
Chronic Myeloid Leukemia
100%
Lymphocyte Depletion
100%
Disease
66%
Graft Versus Host Reaction
33%
Ciclosporin
33%
Host
33%
Immunology and Microbiology
Lymphocyte
100%
Bone Marrow Transplantation
50%
Graft-Versus-Host Disease
25%
Engraftment
25%
Morphology
25%
Host
25%
Ciclosporin
25%
Neutrophil Count
25%
Allogeneic Bone Marrow Transplantation
25%
Ideal Body Weight
25%
T Cell
25%
Allograft
25%